Survival of children under 3 years old with medulloblastoma: A study from the Mexican Cooperative Group for Childhood Malignancies (AMOHP)

Child's Nervous System

Volumn 18, Issue 1-2, 2002, Pages 38-42

  Rivera Luna, Roberto ^a   López, Enrique ^b   Rivera Marquez, Hugo ^b   Rivera Ortegón, Francisco ^c   Altamirano Alvarez, Eduardo ^d   Mercado, Gabriela ^a   Covarrubias, Gilberto ^e   Rueda Franco, Fernando ^a   Marhx Bracho, Alfonso ^a   Gutiérrez, Pedro ^a  

^a INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^b HOSPITAL DE PEDIATRÍA   (Mexico)

^c Hospital Universitario de la Universidad   (Mexico)

^d Hospital del Niño   (Mexico)

^e Hospital del Niño   (Mexico)

Author keywords

Medulloblastoma under 3 years of age; Outcome; Treatment

Indexed keywords

CARBOPLATIN; CARMUSTINE; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; LOMUSTINE; PROCARBAZINE; VINCRISTINE; ANTINEOPLASTIC AGENT;

AGE DISTRIBUTION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILDHOOD CANCER; FEMALE; GROUPS BY AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; METASTASIS; MORBIDITY; MULTIMODALITY CANCER THERAPY; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; CEREBELLUM TUMOR; NEUROSURGERY; POSTERIOR FOSSA; SURVIVAL; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CEREBELLAR NEOPLASMS; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CRANIAL FOSSA, POSTERIOR; FEMALE; HUMANS; INFANT; MALE; MEDULLOBLASTOMA; NEUROSURGICAL PROCEDURES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0036481008     PISSN: 02567040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00381-001-0527-2     Document Type: Article

References (20)

1. Albright AL, Wisoff JH, Zeltzer PM, Boyett JM, Rorke LB, Stanley P (1996) Effects of medulloblastoma resections on outcome in children: report from the Children's Cancer Group. Neurosurgery 38:265-271
2. Chang CH, Housepian EM, Herbert C Jr (1969) An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastoma. Radiology 93:1315-1359
3. Cohen ME, Duffner PK (1994) Brain tumors in children. Principles of diagnosis and treatment. Raven Press, New York, pp 464-466
4. Di Rocco C, Iannelli A, Papacci F, Tamburrini G (1997) Prognosis of medulloblastoma in infants. Child's Nerv Syst 13:388-396
5. Duffner PK, Cohen ML, Thomas PRM (1985) The long term effects of cranial irradiation in the central nervous system. Cancer 56:1841-1847
6. Duffner PK, Horowitz ME, Krischer JP, Friedman HS, Burger PC, Sanford RA, Mulhem NK, James HE, Freeman CR (1993) Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328:1725-1731
7. Goldwein JW, Radcliffe J, Johnson J, Moshang T, Packer RJ, Sutton RLB, Rorke LB, D'Angio GJ (1996) Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma). Int J Radiat Oncol Biol Phys 34:899-904
8. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
9. Krischer JP, Ragab AH, Kun L, Kim TH, Laurent JP, Boyett JM, Cornell CJ, Link M, Luthy AR (1991) Nitrogen mustard, vincristine, procarbazine and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. A Pediatric Oncology Group Study. J Neurosurg 74:905-909
10. Mantel N (1966) Evaluation of the survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170
11. Packer RJ (1990) Chemotherapy for medulloblastoma/primitive neuroectodermal tumors of the posterior fossa. Ann Neurol 28:823-828
12. Packer RJ, Goldwein J, Nicholson HS, Vezina LG, Allen JC, Ris MD, Muraszko K, Rorke LB, Wara WM, Cohen BH, Boyett JM (1999) Treatment of children with medulloblastoma with reduced dose craniospinal radiation therapy and adjuvant chemotherapy: a Children's Cancer Group Study. J Clin Oncol 17:2127-2136
13. Packer RJ, Sutton LN, Elterman R, Lange B, Goldwein J, Nicholson HS, Mulne L, Boyett J, D'Angio G, Wechsler-Jentzsch K (1994) Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 81:690-698
14. Peto R, Pike MC, Armitage P, Breslow EN, Cox OR, Howard SV, Mantel N, McPherson K, Peto J, Smith DG (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1-39
15. Ris MD, Packer R, Goldwein J, Jones-Wallace D, Boyett JM (2001) Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study. J Clin Oncol 19:3470-3476
16. Rivera-Luna R, Leal-Leal C, Cardenas-Cardos R, Gomez-Martinez R, Rueda-Franco F, Marhx-Bracho A (1998) Outcome of children with previously untreated medulloblastoma with two different chemotherapy regimens. Int J Pediatr Hematol Oncol 5:313-322
17. Sands SA, van Gorp WG, Finlay JL (1988) Pilot neuropsychological findings from a treatment regimen consisting of intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. Child's Nerv Syst 14:587-589
18. Schmandt S, Kuhl J (1988) Chemotherapy as prophylaxis and treatment of meningiosis in children less than 3 years of age with medulloblastoma. J Neurooncol 38:187-192
19. Strother D, Ashley D, Kellie SJ, Patel A, Jones-Wallace D, Thompson S, Heideman R, Benaim E, Krance R, Bowman L, Gajjar A (2001) Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study. J Clin Oncol 19:2696-2704
20. Zeltzer PM, Boyett JM, Finlay JL, Leland AA, Rorke LB, Milstein JM, Allen JC, Stevens KR, Stanley Ph, Li H, Wisoff JH, Geyer R, McGuire-Cullen P, Stehbens JA, Shurin SB, Packer RJ (1999) Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 17:832-845